Bioactivity:

Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.

CAS nr:

1335210-23-5

Purity:

98%

Molecular Weight:

314,27

SMILES:

COC(CN(C=C(C([O-])=O)C1=O)C(C(OC)=O)=C1OC)OC

Formula:

C13H16NO8

Pathway:

Microbiology/Virology,Proteases/Proteasome

Target:

HIV Protease,HIV Protease